During the past decade, UCSF Medical Center-Mount Zion conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 79 clinical trials were completed, i.e. on average, 192.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 32 clinical trials were completed. i.e. 246.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCSF Medical Center-Mount Zion" #1 sponsor was "National Cancer Institute (NCI)" with 64 trials, followed by "Children's Oncology Group" with 11 trials sponsored, "Gynecologic Oncology Group" with 11 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 9 trials sponsored and "University of California, San Francisco" with 9 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSF Medical Center-Mount Zion" #1 collaborator was "National Cancer Institute (NCI)" with 59 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 97 different institutions and companies that were collaborators in the rest 73 trials.

According to Clinical.Site data, the most researched conditions in "UCSF Medical Center-Mount Zion" are "HIV Infections" (16 trials), "Prostate Cancer" (7 trials), "Endometrial Clear Cell Adenocarcinoma" (6 trials), "Recurrent Ovarian Carcinoma" (6 trials) and "Colorectal Cancer" (5 trials). Many other conditions were trialed in "UCSF Medical Center-Mount Zion" in a lesser frequency.

Most popular intervention types in "UCSF Medical Center-Mount Zion" are "Drug" (133 trials), "Other" (86 trials), "Biological" (52 trials), "Procedure" (31 trials) and "Radiation" (30 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (58 trials), "Paclitaxel" (24 trials), "Quality-of-Life Assessment" (22 trials), "Bevacizumab" (18 trials) and "Carboplatin" (17 trials). Other intervention names were less common.

The vast majority of trials in "UCSF Medical Center-Mount Zion" are 117 trials for "All" genders, 31 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "UCSF Medical Center-Mount Zion". undefined are not yet recruiting, 12 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 83 completed trials in UCSF Medical Center-Mount Zion, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in UCSF Medical Center-Mount Zion, 20 "Phase 1" clinical trials were conducted, 71 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 12 trials that are defined as “Not Applicable".